NCT03962491

Brief Summary

This project examines the efficacy and feasibility of contingency management (CM), delivered using a novel, fully automated CM app (DynamiCare Rewards), to promote daily self-monitoring of pain symptom severity and related variables (e.g., mood, sleep), as well as Rx opioid, alcohol, marijuana, cannabidiol (CBD), and Rx benzodiazepine use in a sample of chronic pain patients. The project will conduct a 2-arm randomized clinical trial (RCT) comparing those receiving reinforcement escalating with continuous performance of the target behavior (CM group) vs those asked to complete the survey but will not be incentivized (C group).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 24, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

January 24, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2021

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

December 7, 2022

Completed
Last Updated

December 7, 2022

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

May 22, 2019

Results QC Date

October 3, 2022

Last Update Submit

November 11, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Daily Self-monitoring Surveys Completed

    Number of days daily surveys completed

    28-day daily survey period

  • Longest Period of Sustained Adherence to Daily Survey Completion

    Largest number of consecutive days wherein daily surveys were completed

    28-day daily survey period

Secondary Outcomes (2)

  • Daily Survey Completion Time

    28-day daily survey period

  • CM App Acceptability

    28-day follow-up

Other Outcomes (5)

  • Agreement Between Daily Survey and 28-day Follow-up Reports of Alcohol Use

    28-day daily survey period to 28-day follow-up

  • Agreement Between Daily Survey and 28-day Follow-up Reports of Rx Opioid Use

    28-day daily survey period to 28-day follow-up

  • Agreement Between Daily Survey and 28-day Follow-up Reports of Rx Benzodiazepine Use

    28-day daily survey period to 28-day follow-up

  • +2 more other outcomes

Study Arms (2)

Daily Self-Monitoring Surveys

OTHER

Asked to complete daily self-monitoring surveys.

Behavioral: Daily Self-Monitoring Surveys

Daily Self-Monitoring Surveys + Contingency Management

EXPERIMENTAL

Asked to complete daily self-monitoring surveys, with opportunity for monetary rewards.

Behavioral: Daily Self-Monitoring Surveys + Contingency Management

Interventions

Asked to complete a brief (5-minute) survey with questions related to pain experience and related measures every day for 28 days using the DynamiCare smartphone app, with the opportunity for monetary rewards for completing daily surveys.

Daily Self-Monitoring Surveys + Contingency Management

Asked to complete a brief (5-minute) survey with questions related to pain experience and related measures every day for 28 days using the DynamiCare smartphone app.

Daily Self-Monitoring Surveys

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • at least 18 years of age;
  • own a study-compatible smartphone (iPhone or Android device);
  • report non-cancer related chronic pain (consistent daily pain) for 3 months or greater;
  • able to provide informed consent for study participation;
  • used prescription opioids in the past 30 days; and
  • having ever been prescribed 1 or more opioid medication(s) for pain management.

You may not qualify if:

  • currently pregnant;
  • presenting with language barriers, cognitive impairment, or serious medical or psychiatric illness that in the opinion of the Investigator would preclude them from providing informed consent or participating in the study; and
  • visual impairment or motor impairment that would interfere with use of a smartphone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Kathryn Polak, PhD
Organization
Virginia Commonwealth University

Study Officials

  • Dace Svikis, PhD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2019

First Posted

May 24, 2019

Study Start

January 24, 2020

Primary Completion

April 14, 2021

Study Completion

April 14, 2021

Last Updated

December 7, 2022

Results First Posted

December 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations